Position in AMGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,491,140
+$144,914 QoQ
Shares Held
4,238
+3.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Mill Creek Capital Advisors, LLC holds $59,193,747 across 6 Drug Manufacturers - General names. AMGN ranks #2 (2.5% of the industry book) .
All Filings in AMGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,491,140 | 4,238 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,346,226 | 4,113 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,159,277 | 4,108 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,045,362 | 3,744 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,167,689 | 3,748 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,013,628 | 3,889 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,206,354 | 3,744 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,285,731 | 4,115 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,044,307 | 3,673 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,076,906 | 3,739 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,018,062 | 3,788 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $898,958 | 4,049 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,341,470 | 5,549 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $984,637 | 3,749 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||